Plus Library

By pinki@katapult.biz / February 13, 2025

Displaying 576 - 600 of 2,875

Metastatic Colorectal Cancer Therapy

Metastatic Colorectal Cancer Therapy

Richard D. Kim, MD

Colorectal Cancer: Novel Insights

Colorectal Cancer: Novel Insights

Richard Kim, MD

Metastatic Colorectal Cancer Therapy

Metastatic Colorectal Cancer Therapy

Richard Kim, MD

Getting the mCRC patient to surgery – Role of PVE & HVD

Getting the mCRC patient to surgery – Role of PVE & HVD

Ripal Gandhi, MD

The Added Diagnostic Value of Transcatheter CT-Hepatic Arteriography for Intraprocedural Detection of Previously Unknown Colorectal Liver Metastases During Percutaneous Ablation and Impact on the Definitive Treatment Plan

The Added Diagnostic Value of Transcatheter CT-Hepatic Arteriography for Intraprocedural Detection of Previously Unknown Colorectal Liver Metastases During Percutaneous Ablation and Impact on the Definitive Treatment Plan

Susan Van der Lei, MD

Managing Toxicities from Commonly Used Agents in Colorectal Cancer (CRC)

Managing Toxicities from Commonly Used Agents in Colorectal Cancer (CRC)

Terri Pollack - BA - DNP - MSN - APRN - FNP-C

Managing Toxicities from Commonly Used Agents in Colorectal Cancer (CRC)

Managing Toxicities from Commonly Used Agents in Colorectal Cancer (CRC)

Terri Pollack, DNP, APRN, FNP, BA

Eliminate the Barriers for Disparity in Cancer Care in the 21st Century

Eliminate the Barriers for Disparity in Cancer Care in the 21st Century

Chanita Hughes-Halbert, PhD

Eliminate the Barriers for Disparity in Cancer Care in the 21st Century

Eliminate the Barriers for Disparity in Cancer Care in the 21st Century

Chanita Hughes-Halbert, PhD

Cost of Medications: How to Make Them Affordable—Are We on the Right Direction?

Cost of Medications: How to Make Them Affordable—Are We on the Right Direction?

Dina Dumercy McHenry, PharmD, MBA, BCOP, CSSGB

Cost of Medications: How to Make Them Affordable—Are We on the Right Direction?

Cost of Medications: How to Make Them Affordable—Are We on the Right Direction?

Dina Dumercy McHenry, PharmD, MBA, BCOP, CSSGB

Lack of Access to Novel Cancer Therapies: How to Deal and Approach this Problem? Diversity, Equity, & Inclusion

Lack of Access to Novel Cancer Therapies: How to Deal and Approach this Problem? Diversity, Equity, & Inclusion

Edith Peterson Mitchell, MD, MACP, FCPP, FRCP [London]

Lack of Access to Novel Cancer Therapies: How to Deal and Approach this Problem? Diversity, Equity, & Inclusion

Lack of Access to Novel Cancer Therapies: How to Deal and Approach this Problem? Diversity, Equity, & Inclusion

Edith Peterson Mitchell, MD, MACP, FCPP, FRCP [London]

Health Care Disparities in Lung Cancer Genomic Profiling

Health Care Disparities in Lung Cancer Genomic Profiling

Estelamari Rodriguez, MD

Cancer Disparity from Different Angles: How to Tackle It?

Cancer Disparity from Different Angles: How to Tackle It?

John Carpten, PhD

Cancer Disparity from Different Angles: How to Tackle It?

Cancer Disparity from Different Angles: How to Tackle It?

John Carpten, PhD

Are The New Changes in Congress an Answer for Inequity in Terms of Access to Molecular Testing and New Cancer Agents?

Are The New Changes in Congress an Answer for Inequity in Terms of Access to Molecular Testing and New Cancer Agents?

Kashyap Patel, MD, ABOIM

Initiatives to Improve Equity and Inclusion in Healthcare

Initiatives to Improve Equity and Inclusion in Healthcare

Kashyap Patel, MD, ABOIM

Initiatives to Improve Equity and Inclusion in Healthcare

Initiatives to Improve Equity and Inclusion in Healthcare

Kashyap Patel, MD, ABOIM

Are The New Changes in Congress an Answer for Inequity in Terms of Access to Molecular Testing and New Cancer Agents?

Are The New Changes in Congress an Answer for Inequity in Terms of Access to Molecular Testing and New Cancer Agents?

Kashyap Patel, MD, ABOIM

Lack of Equity in Clinical Outcomes in African American and Hispanics with NSCLC

Lack of Equity in Clinical Outcomes in African American and Hispanics with NSCLC

Luis E. Raez, MD

Oncology Payments Models: Where Are We Going?

Oncology Payments Models: Where Are We Going?

Michael Diaz, MD

Oncology Payments Models: Where Are We Going?

Oncology Payments Models: Where Are We Going?

Michael Diaz, MD

Equity in Cancer Care: Efforts Tackling Barriers at the Government and Legislation Levels

Equity in Cancer Care: Efforts Tackling Barriers at the Government and Legislation Levels

Sybil Richard Green, JD, MHA, BS Pharm

Equity in Cancer Care: Efforts Tackling Barriers at the Government and Legislation Levels

Equity in Cancer Care: Efforts Tackling Barriers at the Government and Legislation Levels

Sybil Richard Green, JD, MHA, BS Pharm